SNIBE Showcases Total Lab Automation and Diagnostic Platforms at ADLM 2026

SNIBE is presenting its latest in vitro diagnostic and laboratory automation solutions at ADLM 2026 in Anaheim, California, where attendees can visit the company at Booth 3814. The exhibit highlights SNIBE’s focus on integrated diagnostic workflows spanning immunoassay, clinical chemistry, automation, and broader laboratory testing needs.

A central focus of the exhibit is SATLARS mini-T8, the newest member of SNIBE’s Total Laboratory Automation Solutions. Designed for laboratories with limited space, the system integrates pre-analytical and post-analytical sample handling within a compact 2.2 m² footprint. It automates the sample handling and analysis process from loading to storage, while supporting rapid turnaround through compatibility with SNIBE’s high-throughput analyzers.

Image: Visitors to SNIBE’s booth at ADLM can experience live demos of the company\'s latest cutting-edge solutions (Photo courtesy of SNIBE)

SNIBE is also showcasing its integrated and high-throughput testing systems, including the Biolumi CX Solution-X10+C10, which combines the MAGLUMI X10 immunoassay analyzer with the Biossays C10 biochemistry analyzer. The system enables immunoassay, biochemical, and ISE testing from one sample loading process, reducing sample transfer steps and helping laboratories improve testing efficiency.

The company’s MAGLUMI X8 chemiluminescence immunoassay system is designed for medium- to large-volume laboratories, offering up to 600 tests per hour in a single module and up to 2,400 tests per hour when four modules are combined. SNIBE’s Biossays C10 biochemistry analyzer further supports high-throughput workflows, with up to 2,000 biochemistry tests per hour, 1,000 ISE tests per hour, whole-blood HbA1c testing, and connectivity with laboratory automation systems.